Evidence that Mast Cells Regulate the Cough Hypersensitivity Associated with Eosinophilic Bronchitis
Lung · 2025
DOI: 10.1007/s00408-025-00835-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung, 2025. Verfasst von Li Yu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Tongii Hospital, School of Medicine, Tongii University, Shanghai, 200065, China. Hauptthemen laut MEDLINE: Cough, Mast Cells, Bronchitis, Eosinophilia. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This research was supported by grants from the National Institutes of Health (R01HL 141251 and R21 ES036349).
Abstract (Originalsprache)
PURPOSE: Eosinophils have been implicated as key effectors in the emergence of chronic cough. But causality has not been firmly established, and many patients with cough secondary to eosinophilic bronchitis (EB) are likely misdiagnosed as asthmatics based on successful empiric trials using inhaled corticosteroids. Better diagnostics and more precise therapeutic strategies for EB and other diseases that lead to chronic cough remain important but unmet clinical needs. METHODS: With the goal of better defining the mechanisms of cough in disease, we established a model of EB in guinea pigs using allergen challenges that induce a cough hypersensitivity responsive to steroid therapy. RESULTS: The heightened cough responsiveness associated with the eosinophilic inflammation was mimicked by LTD4 inhalation and prevented by cysLT1 receptor blockade with pranlukast or montelukast. But cysLT1 receptor antagonism failed to prevent the eosinophilic infiltration of the airways evoked by allergen challenge. Additionally, inhalation of the mast cell selective stimulant Compound 48/80 mimicked the effects of allergen challenge on cough but failed to significantly increase eosinophilic infiltration of the airways. We also observed that thromboxane A2, through TP receptor engagement, acts downstream from and simultaneously with the leukotrienes to promote cough hypersensitivity in EB. CONCLUSIONS: These results suggest that mast cells and not eosinophils may be essential to the emergence of cough hypersensitivity in EB. We speculate that therapeutic strategies targeting mast cells, cysLT1 receptors, and TP receptors may represent endotype-specific treatments for chronic cough.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Tongii Hospital, School of Medicine, Tongii University, Shanghai, 200065, China.
- Johns Hopkins Asthma and Allergy Center, Baltimore, MD, 21224, USA.
- Johns Hopkins Asthma and Allergy Center, Baltimore, MD, 21224, USA. bjc@jhmi.edu.
Förderung
- This research was supported by grants from the National Institutes of Health (R01HL 141251 and R21 ES036349)
Zitieren
APA
Yu, L., Liu, Q., & Canning, B. J. (2025). Evidence that Mast Cells Regulate the Cough Hypersensitivity Associated with Eosinophilic Bronchitis. Lung. https://doi.org/10.1007/s00408-025-00835-1
Vancouver
Yu L, Liu Q, Canning BJ. Evidence that Mast Cells Regulate the Cough Hypersensitivity Associated with Eosinophilic Bronchitis. Lung. 2025. doi:10.1007/s00408-025-00835-1
BibTeX
@article{Yu2025,
author = {Yu, Li and Liu, Qi and Canning, Brendan J},
title = {Evidence that Mast Cells Regulate the Cough Hypersensitivity Associated with Eosinophilic Bronchitis},
journal = {Lung},
year = {2025},
doi = {10.1007/s00408-025-00835-1}
}
EUVIMED